BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35569122)

  • 1. TGIF1 overexpression promotes glioma progression and worsens patient prognosis.
    Wang B; Ma Q; Wang X; Guo K; Liu Z; Li G
    Cancer Med; 2022 Dec; 11(24):5113-5128. PubMed ID: 35569122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.
    Wu X; Feng F; Yang C; Zhang M; Cheng Y; Zhao Y; Wang Y; Che F; Zhang J; Heng X
    J Mol Neurosci; 2019 Dec; 69(4):527-537. PubMed ID: 31377983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients.
    Liu Z; Zhang W; Cheng X; Wang H; Bian L; Wang J; Han Z; Wang Y; Lian X; Liu B; Ren Z; Zhang B; Jiang Z; Lin Z; Gao Y
    Mol Med; 2021 May; 27(1):52. PubMed ID: 34051735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.
    Liu Z; Shen F; Wang H; Li A; Wang J; Du L; Liu B; Zhang B; Lian X; Pang B; Liu L; Gao Y
    Cell Cycle; 2020 Jul; 19(13):1632-1640. PubMed ID: 32436804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGIF2 is a potential biomarker for diagnosis and prognosis of glioma.
    Zhang W; Zhang L; Dong H; Peng H
    Front Immunol; 2024; 15():1356833. PubMed ID: 38629068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells.
    Liu Z; Wang H; Jia Y; Wang J; Wang Y; Bian L; Liu B; Lian X; Zhang B; Ren Z; Zhang W; Dai W; Gao Y
    Cancer Med; 2021 Aug; 10(15):5218-5234. PubMed ID: 34264013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
    Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
    Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERN1 knockdown modifies the effect of glucose deprivation on homeobox gene expressions in U87 glioma cells.
    Tsymbal DO; Minchenko DO; Khita OO; Rudnytska OV; Viletska YM; Lahanovska YO; He Q; Liu K; Minchenko OH
    Endocr Regul; 2020 Jul; 54(3):196-206. PubMed ID: 32857719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma.
    Qi S; Song Y; Peng Y; Wang H; Long H; Yu X; Li Z; Fang L; Wu A; Luo W; Zhen Y; Zhou Y; Chen Y; Mai C; Liu Z; Fang W
    PLoS One; 2012; 7(6):e38842. PubMed ID: 22761708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XTP8 stimulates migration and invasion of gastric carcinoma through interacting with TGIF1.
    Jia K; Wen QH; Zhao X; Cheng JM; Cheng L; Xi M
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2412-2420. PubMed ID: 32196592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High TRAF3IP3 Level Predicts Poor Prognosis of Patients with Gliomas.
    Yang G; Tang S; Zhang J; Qin L
    World Neurosurg; 2021 Apr; 148():e436-e449. PubMed ID: 33444836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Chinese Medicine, Shezhi Huangling Decoction, Inhibits the Growth and Metastasis of Glioma Cells via the Regulation of miR-1298-5p/TGIF1 Axis.
    Liu X; Ju J; Liu Q; Zhu Z; Liu C
    Cancer Manag Res; 2020; 12():5677-5687. PubMed ID: 32765071
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Liu Z; Ren Z; Zhang C; Qian R; Wang H; Wang J; Zhang W; Liu B; Lian X; Wang Y; Guo Y; Gao Y
    Front Oncol; 2021; 11():608748. PubMed ID: 34976781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
    Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
    Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of
    Yu Z; Liu Z; Lian X; Cheng X; Liu B; Zhang B; Wang H; Wang J; Li A; Ren Z; Pang B; Qian R; Gao Y
    Cell Cycle; 2022 Nov; 21(22):2387-2402. PubMed ID: 35852388
    [No Abstract]   [Full Text] [Related]  

  • 17. HDAC3 deteriorates colorectal cancer progression via microRNA-296-3p/TGIF1/TGFβ axis.
    Li J; Hu M; Liu N; Li H; Yu Z; Yan Q; Zhou M; Wang Y; Song Y; Pan G; Liang F; Chen R
    J Exp Clin Cancer Res; 2020 Nov; 39(1):248. PubMed ID: 33203425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of transforming growth factor β induced factor homeobox 1 represses NPC1L1 and lowers markers of intestinal cholesterol absorption.
    Parini P; Melhuish TA; Wotton D; Larsson L; Ahmed O; Eriksson M; Pramfalk C
    Atherosclerosis; 2018 Aug; 275():246-255. PubMed ID: 29980051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing Pre-B-cell leukemia homeobox 3 decreases the proliferation of human glioma cells in vitro and in vivo.
    Xu X; Cai N; Bao Z; You Y; Ji J; Liu N
    J Neurooncol; 2017 Dec; 135(3):453-463. PubMed ID: 28856521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TUBA1C expression promotes proliferation by regulating the cell cycle and indicates poor prognosis in glioma.
    Gui S; Chen P; Liu Y; Chen Q; Cheng T; Lv S; Zhou T; Song Z; Xiao J; He W; Yuan S; Cheng Z
    Biochem Biophys Res Commun; 2021 Nov; 577():130-138. PubMed ID: 34517210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.